Skip to main content

Table 1 Clinical and genetic features of SPG5 patients

From: Potential markers for sample size estimations in hereditary spastic paraplegia type 5

No

Family

Gender

Mutation cDNA

Consanguineous family/family history

Age at onset(y)

Age at enrollment(y)

Disease duration (y)

SPRS†

Disability score‡

1

F1-II-2

Female

c.259 + 2T > C

c.1190C > T

No/No

3

27

24

38

6

2

F2-II-1

Male

c. 334C > T hom

No/No

12

21

9

15

3

3

F3-II-1

Female

c. 334C > T hom

No/No

27

41

14

14

3

4

F4-II-2

Male

c. 334C > T hom

No/No

10

30

20

21

5

5

F5-II-1

Female

c. 334C > T hom

No/No

17

31

14

24

5

6

F6-IV-1

Male

c. 334C > T hom

Yes/No

12

26

14

13

3

7

F7-II-3

Male

c. 334C > T hom

No/No

4

14

10

25

5

8

F8-II-1

Male

c. 334C > T hom

No/No

1

17

16

15

3

9

F9-IV-2

Male

c. 334C > T hom

Yes/Yes

11

34

23

4

2

10

F10-II-3

Male

c. 334C > T hom

No/No

26

42

16

19

4

11

F11-IV-3

Male

c. 334C > T hom

Yes/Yes

8

45

37

26

4

12

F14-II-1

Male

c. 334C > T hom

No/No

11

17

6

11

3

13

F17-II-1

Female

c. 334C > T hom

No/No

10

18

8

14

3

14

F9-IV-1

Female

c. 334C > T hom

Yes/Yes

25

37

12

2

2

15

F11-IV-1

Male

c. 334C > T hom

Yes/Yes

9

49

40

22

5

16

F18-III-1

Male

c. 334C > T hom

No/Yes

5

13

8

8

3

17

F18-II-7

Female

c. 334C > T hom

No/Yes

18

38

20

6

3

No

Harding classification

MMSE

Dorsal column dysfunction

Urinary symptoms

Cerebellar ataxia

Other symptoms

   

1

Pure

24

Yes

No

No

No

   

2

Pure

27

Yes

No

No

No

   

3

Pure

30

Yes

No

No

No

   

4

Pure

29

Yes

No

No

No

   

5

Pure

29

Yes

No

No

No

   

6

Complex

29

Yes

No

No

Epilepsy

   

7

Pure

29

Yes

No

No

No

   

8

Pure

29

Yes

No

No

No

   

9

Pure

29

Yes

No

No

No

   

10

Pure

28

Yes

Yes

No

No

   

11

Pure

29

Yes

No

No

No

   

12

Pure

29

Yes

No

No

No

   

13

Pure

29

Yes

No

No

No

   

14

Pure

28

Yes

No

No

No

   

15

Pure

29

Yes

No

No

No

   

16

Pure

27

Yes

No

No

No

   

17

Pure

28

Yes

No

No

No

   
  1. SPG5, spastic paraplegias type 5; MMSE, mini-mental state examination
  2. Spastic Paraplegia Rating Scale (SPRS), range from zero (no disease manifestation) to a maximum of 52 points (most severe disease manifestation)
  3. Disability score (0 = no functional handicap, 1 = no functional handicap but signs at examination; 2 = mild, able to run, walking unlimited; 3 = moderate, unable to run, limited walking without aid; 4 = severe, walking with one stick; 5 = walking with two sticks; 6 = unable to walk, requiring wheelchair; 7 = confined to bed)